← Back to News · 1 outlet · Story cluster #534

ImmunityBio Inc. (NASDAQ: IBRX) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

How different outlets framed the same story — bias, verdict, and framing side by side.

🤖 D.R.A.F.T. Summary

ImmunityBio Inc. (NASDAQ: IBRX) Investigated for Potential Federal Securities Laws Violations

NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a top complex litigation law firm, is investigating ImmunityBio Inc. (NASDAQ: IBRX) (“ImmunityBio” or the “Company”) for potential violations of the federal securities laws.

Outlets covering this story

Montreal Gazette CENTER

Only one perspective covered this story — no diversity detected

📰

Side-by-Side Outlet Comparison — Starter+

See how 1 outlets framed this story — bias by source, F.A.C.T. framing analysis, and verdict side by side.

Unlock with Starter →

See plans